An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biochemical Journal

• Publication date

  1984-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ2220183PMID 6089756PMCID PMC1144159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular basis of insulin action.

  1985cited by this paper
• Insulin controls intracellular cyclic AMP concentrations in hepatocytes by activating specific cyclic AMP phosphodiesterases: phosphorylation of the peripheral plasma membrane enzyme.

  1984cited by this paper
• N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.

  1984cited by this paper
• Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase.

  1983cited by this paper
• Diabetes and the Endocrine Pancreas

  1983cited by this paper
• Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes.

  1983cited by this paper
• Guanine nucleotides can activate the insulin‐stimulated phosphodiesterase in liver plasma membranes

  1983cited by this paper
• Insulin activates the plasma-membrane and dense-vesicle cyclic AMP phosphodiesterase in hepatocytes by distinct routes.

  1983cited by this paper
• Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes.

  1983cited by this paper
• Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.

  1982cited by this paper
• Identification and properties of cyclic nucleotide phosphodiesterases.

  1982cited by this paper
• Simulations of the roles of multiple cyclic nucleotide phosphodiesterases.

  1982cited by this paper
• Energy-dependent activation and magnesium--dependent inactivation of hepatocyte hormone-sensitive phosphodiesterase.

  1981cited by this paper
• Membrane phosphorylation: a crucial role in the action of insulin, EGF, and pp60src?

  1981cited by this paper
• Characterization of the phosphorylated form of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.

  1981cited by this paper
• Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.

  1981cited by this paper
• Hormone-sensitive cAMP phosphodiesterase in liver and fat cells

  1981cited by this paper
• Insulin triggers cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase

  1980cited by this paper
• Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.

  1978cited by this paper
• THE ROLE OF CYCLIC AMP IN THE INTERACTION OF GLUCAGON AND INSULIN IN THE CONTROL OF LIVER METABOLISM *

  1971cited by this paper
• An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.

  1970cited by this paper
• Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.

  1968cited by this paper

• In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.

  2005cites this paper
• Possible roles of cAMP and Ca2+ in the regulation of miracidial transformation inSchistosoma mansoni

  2004cites this paper
• Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.

  2001cites this paper
• Low Level Cyclic Adenosine 3’,5’-Monophosphate Accumulation Analysis of [des-His’,des-Phe’,Glu’]Glucagon-NH, Identifies Glucagon Antagonists from Weak Partial Agonists/Antagonists*

  2001cites this paper
• Low Level Cyclic Adenosine 3’,5’-Monophosphate Accumulation Analysis of [des-His’,des-Phe’,Glu’]Glucagon-NH, Identifies Glucagon Antagonists from Weak Partial Agonists/Antagonists*

  2001cites this paper
• The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions.

  1998cites this paper
• Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors.

  1997cites this paper
• Effect of streptozotocin‐induced diabetes on phosphodiesterase activity in rat luteal cells

  1996cites this paper
• Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.

  1996cites this paper
• Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMP.

  1995cites this paper
• Insulin counters the glycogenolytic effect of arginine vasotocin in liver pieces from the axolotl, Ambystoma mexicanum, cultured in vitro.

  1993cites this paper
• External stimuli and intracellular signalling in the modification of the nematode surface during transition to the mammalian host environment

  1993cites this paper
• Extracellular calcium modulates insulin's action on enzymes controlling cyclic AMP metabolism in intact hepatocytes.

  1993cites this paper
• Regulation of cyclic AMP synthesis and degradation is modified in rat liver at late gestation.

  1992cites this paper
• Insulin-Sensitive cAMP Phosphodiesterase

  1990cites this paper
• Involvement of a pertussis toxin-sensitive G protein in the regulation of angiotensinogen production by an angiotensin II analog in HepG2 cells.

  1990cites this paper
• The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations.

  1990cites this paper
• Glucagon activates two distinct signal transduction systems in hepatocytes, which leads to the desensitization of G-protein-regulated adenylate cyclase, the phosphorylation and inactivation of Gi-2 and the phosphorylation and stimulation of a specific cyclic AMP phosphodiesterase

  1990cites this paper
• CHAPTER 22 – Insulin and Its Interaction with G Proteins

  1990cites this paper
• ‘Cross-Talk’ and the Regulation of Repatocyte Adenylate Cyclase Activity: Desensitization, G1 and Cyclic AMP Phosphodiesterase Regulation

  1990cites this paper
• Activation and phosphorylation of the 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase by cyclic AMP-dependent protein kinase.

  1989cites this paper
• Insulin stimulates the tyrosyl phosphorylation and activation of the 52 kDa peripheral plasma-membrane cyclic AMP phosphodiesterase in intact hepatocytes.

  1989cites this paper
• Effects of vanadate on protein kinases in rat hepatocytes.

  1989cites this paper
• Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.

  1989cites this paper
• An insulin mediator preparation serves to stimulate the cyclic GMP activated cyclic AMP phosphodiesterase rather than other purified insulin-activated cyclic AMP phosphodiesterases.

  1988cites this paper
• Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi.

  1988cites this paper
• The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.

  1987cites this paper
• Glucagon desensitisation of adenylate cyclase in hepatocytes: an action mediated by a distinct population of glucagon receptors coupled to inositol phospholipid metabolism

  1987cites this paper
• The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity.

  1987cites this paper
• The role of insulin in the modulation of glucagon-dependent control of phenylalanine hydroxylation in isolated liver cells.

  1987cites this paper
• The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms.

  1987cites this paper
• Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat.

  1987cites this paper
• Synergistic inhibition of hepatic glycogenolysis in the presence of insulin and a cAMP antagonist.

  1986cites this paper
• Synergistic inhibition of glucagon-induced effects on hepatic glucose metabolism in the presence of insulin and a cAMP antagonist.

  1986cites this paper
• Early events in insulin actions.

  1986cites this paper
• The phorbol ester TPA inhibits cyclic AMP phosphodiesterase activity in intact hepatocytes

  1986cites this paper
• Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.

  1986cites this paper
• Reversal of glucose-induced inhibition of newborn rat liver mitochondrial maturation by administration of alkylxanthines at birth.

  1986cites this paper
• Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture.

  1986cites this paper
• Epidermal growth factor mimics insulin effects in rat hepatocytes.

  1986cites this paper
• The action of islet activating protein (pertussis toxin) on insulin's ability to inhibit adenylate cyclase and activate cyclic AMP phosphodiesterases in hepatocytes.

  1986cites this paper
• Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils.

  1986cites this paper
• Mechanism of insulin's stimulatory action on glucose transport in the isolated rat adipose cell.

  1985cites this paper
• N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.

  1984cites this paper